154 related articles for article (PubMed ID: 15684704)
1. Gene disruption by regulated short interfering RNA expression, using a two-adenovirus system.
Kuninger D; Stauffer D; Eftekhari S; Wilson E; Thayer M; Rotwein P
Hum Gene Ther; 2004 Dec; 15(12):1287-92. PubMed ID: 15684704
[TBL] [Abstract][Full Text] [Related]
2. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study.
Pluta K; Diehl W; Zhang XY; Kutner R; Bialkowska A; Reiser J
BMC Biotechnol; 2007 Jul; 7():41. PubMed ID: 17634114
[TBL] [Abstract][Full Text] [Related]
4. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
Cheng TL; Chang WT
Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus vector-mediated doxycycline-inducible RNA interference.
Hosono T; Mizuguchi H; Katayama K; Xu ZL; Sakurai F; Ishii-Watabe A; Kawabata K; Yamaguchi T; Nakagawa S; Mayumi T; Hayakawa T
Hum Gene Ther; 2004 Aug; 15(8):813-9. PubMed ID: 15319038
[TBL] [Abstract][Full Text] [Related]
6. An effective gene-knockdown using multiple shRNA-expressing adenovirus vectors.
Motegi Y; Katayama K; Sakurai F; Kato T; Yamaguchi T; Matsui H; Takahashi M; Kawabata K; Mizuguchi H
J Control Release; 2011 Jul; 153(2):149-53. PubMed ID: 21515317
[TBL] [Abstract][Full Text] [Related]
7. Rapid construction of small interfering RNA-expressing adenoviral vectors on the basis of direct cloning of short hairpin RNA-coding DNAs.
Mizuguchi H; Funakoshi N; Hosono T; Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T
Hum Gene Ther; 2007 Jan; 18(1):74-80. PubMed ID: 17187476
[TBL] [Abstract][Full Text] [Related]
8. Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors.
Fish RJ; Kruithof EK
BMC Mol Biol; 2004 Aug; 5():9. PubMed ID: 15291968
[TBL] [Abstract][Full Text] [Related]
9. Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1.
Matthess Y; Kappel S; Spänkuch B; Zimmer B; Kaufmann M; Strebhardt K
Oncogene; 2005 Apr; 24(18):2973-80. PubMed ID: 15735719
[TBL] [Abstract][Full Text] [Related]
10. Improving adenovirus vector-mediated RNAi efficiency by lacking the expression of virus-associated RNAs.
Machitani M; Sakurai F; Katayama K; Tachibana M; Suzuki T; Matsui H; Yamaguchi T; Mizuguchi H
Virus Res; 2013 Dec; 178(2):357-63. PubMed ID: 24055658
[TBL] [Abstract][Full Text] [Related]
11. Inducible shRNA expression for application in a prostate cancer mouse model.
Czauderna F; Santel A; Hinz M; Fechtner M; Durieux B; Fisch G; Leenders F; Arnold W; Giese K; Klippel A; Kaufmann J
Nucleic Acids Res; 2003 Nov; 31(21):e127. PubMed ID: 14576327
[TBL] [Abstract][Full Text] [Related]
12. Efficient lentiviral vectors for short hairpin RNA delivery into human cells.
An DS; Xie Y; Mao SH; Morizono K; Kung SK; Chen IS
Hum Gene Ther; 2003 Aug; 14(12):1207-12. PubMed ID: 12908971
[TBL] [Abstract][Full Text] [Related]
13. Silencing of mammalian genes by tetracycline-inducible shRNA expression.
Kappel S; Matthess Y; Kaufmann M; Strebhardt K
Nat Protoc; 2007; 2(12):3257-69. PubMed ID: 18079726
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells.
Long M; Yin G; Liu L; Lin F; Wang X; Ren J; Wei J; Dong K; Zhang H
Cancer Gene Ther; 2012 Apr; 19(4):271-81. PubMed ID: 22281755
[TBL] [Abstract][Full Text] [Related]
15. Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells.
Miyagishi M; Sumimoto H; Miyoshi H; Kawakami Y; Taira K
J Gene Med; 2004 Jul; 6(7):715-23. PubMed ID: 15241778
[TBL] [Abstract][Full Text] [Related]
16. Development of a tightly regulated U6 promoter for shRNA expression.
Lin X; Yang J; Chen J; Gunasekera A; Fesik SW; Shen Y
FEBS Lett; 2004 Nov; 577(3):376-80. PubMed ID: 15556613
[TBL] [Abstract][Full Text] [Related]
17. Construction, modification and evaluation of apolipoprotein A-I promoter-driven shRNA expression vectors against hTERT.
Ren X; Ma Y; Xu M; Chen T; Zhang Z; Zhang Y
Plasmid; 2011 Jan; 65(1):42-50. PubMed ID: 21087625
[TBL] [Abstract][Full Text] [Related]
18. A novel approach for the construction of multiple shRNA expression vectors.
Gou D; Weng T; Wang Y; Wang Z; Zhang H; Gao L; Chen Z; Wang P; Liu L
J Gene Med; 2007 Sep; 9(9):751-63. PubMed ID: 17657830
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions.
Eckstein A; Grössl T; Geisler A; Wang X; Pinkert S; Pozzuto T; Schwer C; Kurreck J; Weger S; Vetter R; Poller W; Fechner H
Antiviral Res; 2010 Oct; 88(1):86-94. PubMed ID: 20708037
[TBL] [Abstract][Full Text] [Related]
20. Generation of stable human cell lines with Tetracycline-inducible (Tet-on) shRNA or cDNA expression.
Gomez-Martinez M; Schmitz D; Hergovich A
J Vis Exp; 2013 Mar; (73):e50171. PubMed ID: 23486277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
